N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phenylsulfanyl)oxan-3-yl]acetamide
Structure Info
- Chemspace ID
- CSSS00027602041 (In-Stock Screening Compounds)
- CAS
- 128960-84-9
- IUPAC Name
- N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phenylsulfanyl)oxan-3-yl]acetamide
- Mol formula
- C14H19NO5S
- Mol weight
- 313 Da
- Catalog Number(s)
- 128960-84-9, AKOS034801222, CSC027602041, OSSK_404806, Z1800406675
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.49
- Heavy atoms count
- 21
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 99
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 4
![Chemical structure of N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phenylsulfanyl)oxan-3-yl]acetamide (C14H19NO5S) - CSSS00027602041](/st/structure/200/dd9f5f180949c5f5ffdcebd19c22cb43/CC%2528%253DO%2529N%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540H%255D1SC1%253DCC%253DCC%253DC1.png "C14H19NO5S")
- Zoom the structure
- CSSS00027602041
Items Overall 16 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 1 mg | 83.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 2 mg | 85.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 5 mg | 91.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 10 mg | 102.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 20 mg | 123.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 1 mg | 88.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 2 mg | 93.50 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 mg | 107.80 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 10 mg | 118.80 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 15 mg | 132.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 20 mg | 145.20 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 30 mg | 165.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 50 mg | 231.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 100 mg | 319.00 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 3 umol | 93.50 | |
| Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 umol | 99.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of [(2R,3S,4R,5R,6S)-3,4-bis(acetyloxy)-5-acetamido-6-(phenylsulfanyl)oxan-2-yl]methyl acetate - CSSS00161007688](/st/structure/200/39a963d2c72163fb08e68291c4bc0de5/CC%2528%253DO%2529N%255BC%2540H%255D1%255BC%2540%2540H%255D%2528O%255BC%2540H%255D%2528COC%2528C%2529%253DO%2529%255BC%2540%2540H%255D%2528OC%2528C%2529%253DO%2529%255BC%2540%2540H%255D1OC%2528C%2529%253DO%2529SC1%253DCC%253DCC%253DC1.png)
![Chemical structure of [(2R,3S,4R,5R,6S)-3,4-bis(acetyloxy)-5-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-6-(phenylsulfanyl)oxan-2-yl]methyl acetate - CSSS02267485254](/st/structure/200/851ad9f02feead1844437f9dd1764ebb/CC%2528%253DO%2529OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528SC2%253DCC%253DCC%253DC2%2529%255BC%2540%2540H%255D%2528%255BC%2540%2540H%255D%2528OC%2528C%2529%253DO%2529%255BC%2540%2540H%255D1OC%2528C%2529%253DO%2529N1C%2528%253DO%2529C2%253DC%2528C%253DCC%253DC2%2529C1%253DO.png)
Similarity Analogs
![Chemical structure of N-{2-[(4-fluorophenyl)sulfanyl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}acetamide - CSSS00132917166](/st/structure/200/3e4a5f33092ff36885a3458407d90439/CC%2528%253DO%2529NC1C%2528O%2529C%2528O%2529C%2528CO%2529OC1SC1%253DCC%253DC%2528F%2529C%253DC1.png)
![Chemical structure of N-[4,5-dihydroxy-6-(hydroxymethyl)-2-phenoxyoxan-3-yl]acetamide - CSSS00028316495](/st/structure/200/e90a786bbc205068eeefb4fe30925ebb/CC%2528%253DO%2529NC1C%2528O%2529C%2528O%2529C%2528CO%2529OC1OC1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenoxyoxan-3-yl]acetamide - CSSS00000134700](/st/structure/200/8c12d404390fcdc3f72a76d1bc1f8a7b/CC%2528%253DO%2529N%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540H%255D1OC1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[8-hydroxy-2-phenyl-6-(phenylsulfanyl)-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]acetamide - CSSS00132917169](/st/structure/200/8d157daa6cb4c097569363181bc5c7d9/CC%2528%253DO%2529NC1C%2528O%2529C2OC%2528OCC2OC1SC1%253DCC%253DCC%253DC1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide - CSSS00000007434](/st/structure/200/634b003dd5dc47874bfbc79a3709453f/CC%2528%253DO%2529NC1C%2528O%2529C%2528O%2529C%2528CO%2529OC1OCC1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(2S,3R,4R,5S,6R)-2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide - CSSS00000131673](/st/structure/200/14a03647d976949835c243683e73c1bd/CC%2528%253DO%2529N%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540%2540H%255D1OCC1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(2S,3R,4R,5R,6R)-2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide - CSSS00020661186](/st/structure/200/82b6fb5344487faf027813487365e1dc/CC%2528%253DO%2529N%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540%2540H%255D1OCC1%253DCC%253DCC%253DC1.png)
